Press Release / July 23, 2024
Our mission is to deliver transformational therapies for solid tumors and I&I diseases in the form of multifunctional antibodies that create immune synapses to precisely activate or inhibit T cells.
We have a world class team with a proven track record of success, which positions us well to advance the next generation of highly innovative medicines that redefine the